Eprex®: Clinical Trials

5 trials of Eprex®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 terminated. 4 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Active not recruiting 1
Phase 41Terminated 1

Follow Eprex®: new trials by email Literature Review of Eprex® trials Research Report on Eprex®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
Luspatercept, Epoetin alfa - Myelodysplastic Syndromes
Phase 3Active not recruitingCelgene3632019-01-022024-11-20
Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients
CinnaPoietin®, Eprex®, Nephrovit - Anemia in End-Stage Renal Disease
Phase 3CompletedCinnagen1562016-06-222019-12-18
Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)
EPREX®, EPIAO® - Renal Anemia
Phase 3CompletedShenyang Sunshine Pharmaceutical Co., LTD.2072015-12-012022-11-23
Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
EPIAO®, EPREX® - Renal Anaemia
Phase 4TerminatedShenyang Sunshine Pharmaceutical Co., LTD.162015-08-012020-10-22
Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients
HX575 epoetin alfa Hexal AG, ERYPO®, Janssen-Cilag - Anemia
Phase 3CompletedSandoz4782004-04-012023-07-03

Conditions studied

Anemia (3)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Kidney Failure, Chronic (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD. (2)  ·  Celgene (1)  ·  Cinnagen (1)  ·  Sandoz (1)

Countries

Austria (2)  ·  Germany (2)  ·  Russia (2)  ·  Thailand (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Greece (1)  ·  Hungary (1)  ·  Iran (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Bolong Miao, Doctoral (1)  ·  Marianne Haag-Weber, Prof. (1)

Results publications

PMID 30253403, PMID 36451454, PMID 37311468, PMID 39038479, PMID 40377899, PMID 41549790